학술논문

Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy
Document Type
Article
Source
In: Blood. (Blood, 29 February 2024, 143(9):786-795)
Subject
Language
English
ISSN
15280020
00064971